Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Over-the-Counter (OTC) Analgesics Market Size to Worth Around USD 38.45 Billion by 2029, Says Brandessence Market Research

This image opens in the lightbox

News provided by

Brandessence Market Research And Consulting Private Limited

04 Jan, 2023, 12:44 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Jan. 4, 2023 /PRNewswire/ -- The Global Over-the-Counter (OTC) Analgesics Market was worth USD 26.5 billion in 2022. It is anticipated to the industry to reach a valuation of 38.45 billion by 2029, registering a CAGR of 5.5% over the forecast duration of 2022-2029.

Over-the-counter analgesics are pain relieving medicines that can be bought by consumers even without showing a doctor's prescription. The instructions written on the medicine should be carefully followed by the user so as to prevent side effects. These medicines are easily available across pharmacies and other drug distribution stores. They are quite affordable in nature and can provide instance relief to minor fever, headaches, and odd joint pains, among others. The most common OTC analgesics are Tylenol, Aspirin, NSAIDs, and Acetaminophen, among others.

Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/17

Global Over-the-Counter (OTC) Analgesics Market Outlook (2022-2029)

The increasing geriatric population base, growing prevalence chronic diseases, and rising self-medication trends are creating lucrative opportunities for this industry vertical to amass notable gains.

Furthermore, technological advancements in the field, booming e-commerce sector, along with growing R&D investments in the field are adding momentum to the development of this business vertical.

Moreover, rising health cognizance of the masses, prompt internet proliferation, and increasing frequency of seasonal flus are augmenting the outlook of this market sphere.

Alongside, various pharmaceutical companies are enhancing their OTC drugs portfolio. This in turn is paving profitable prospects for the Global Over-the-Counter (OTC) Analgesics Market.

On the contrary, threat of side effect posed by OTC drugs is hindering the remuneration scope of this business vertical.

Competitive Hierarchy

The prominent players characterizing the competitive terrain of the Global Over-the-Counter (OTC) Analgesics Market are Bayer AG, Pfizer Inc., Cipla Inc., GlaxoSmithKline plc, Perrigo Co. Plc, Johnson & Johnson, Reckitt Benckiser Group plc, Piramal Enterprises Ltd., AstraZeneca PLC, and Sun Pharmaceutical Industries Ltd.

These players are striving hard to enhance their overall market position. They are participating in the formulation of various growth inducing strategies such as mergers & acquisitions, collaborations, partnerships, and new product launches, among others to witness robust financial gains and emerge as global leaders.

Segmental Outlook

By Drugs:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Acetaminophen
  • Other Analgesics

By Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/17

Region-Wise Outlook

Which is the most dominant region in the industry?

North America is projected to amass notable gains over the stipulated timeframe over 2022-2028. This is attributable to the growing prevalence of chronic ailments, increasing ageing population base, booming pharmaceutical sector, and rising popularity of e-commerce channels.

How is Asia Pacific faring in this marketplace?

Asia Pacific is anticipated to capture a substantial revenue share over the estimated timeline owing to the increasing self-medication trends, growing R&D investments, frequently occurring seasonal flus, and rising health cognizance among the masses.

Category-Wise Insights

Which is the fastest growing drugs segment in this business sphere?

The Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment has emerged as one of the fastest growing segments in this industry. This is ascribed to the efficacy of these drugs to reduce pain caused by ailments like arthritis by slowing down the tissue damage.

Which distribution channel segment is presently leading the market?

Online pharmacies channels segment is currently leading the industry in terms of market share. This is credited to the rapid internet proliferation and doorstep delivery options provided by online shopping channels.

Comparing the historical outlook and ongoing trends of this market

This business sphere has been gaining massive momentum over the assessment duration owing to the influence of various growth inducers.

There has been a rising prevalence of chronic and lifestyle diseases across the globe. Many of these illnesses lead to the occurrence of acute aches in various parts of the bodies. Some even result in the frequent occurrence of fever. It is not possible for the patients to regularly visit healthcare centers to treat every minor symptom caused by their long-term ailments. Therefore, they are shifting their preference towards OTC analgesics to get instant relief for the pain related symptoms caused by long term chronic or lifestyle-based diseases.

The cost effectiveness of these drugs is further escalating their demand worldwide. There has been a steep rise in the number of generic OTC analgesics which are easily availability in medical stores and are also easily affordable for the masses. These factors are stimulating the dynamics of this business sphere.

Due to widespread internet proliferation and rapid adoption of smart devices, e-commerce channels are gaining massive traction. Various e-commerce providers offer online medicine delivery services. It is not necessary for the customers to upload any prescription to place an order for over-the-counter analgesics. This in turn is bolstering the growth of the Global Over-the-Counter (OTC) Analgesics Market.

Increase in the geriatric population base us another expansion catalyst for this industry.  Our immune system weakens as we age, and our bodies starts losing vital nutrients and other components. This leads to the occurrence of odd aches across various parts of the body. This necessitates the consumption of pain killers among the elderly population base.

On Special Requirement Over-the-Counter (OTC) Analgesics Market Report is also available for below region:

North America

  • U.S, Canada

Europe

  • Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

  • South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Major Developments

In July 2022, the Spanish Medicines Agency announced the launch of its new pain killer range produced by the amalgamation of ibuprofen and paracetamol.

Purchase Copy of Report @ https://brandessenceresearch.com/Checkout?report_id=17

Related Reports:

  • Cryogenic Tank Market worth $11.09 billion by 2029 - Exclusive Report by Brandessence Market Research
  • Concrete Repair Mortars Market Is Expected to Grasp the Value of USD 5.74 Billion with Growing CAGR of 8.34% by 2029 | Brandessence Market Research
  • Emulsion Polymers Market Size was US$ 30.73 billion in 2022 and it is expected to reach US$ 49.84 billion by the end of 2028, with a CAGR of 8.4 % - Brandessence Market Research
  • Artificial Insemination Market to Touch USD 3.1 Billion | Industry Revenue, Growth Analysis and Industry Forecast 2028 | Brandessence Market Research
  • 15% CAGR To Take Vitamin Water Market Revenue to $ 2208.22 Million by 2028 | Brandessence Market Research
  • Acute Repetitive Seizures Market Growth Trends 2022 Latest Challenges, Recent Opportunities, Emerging Technologies, Business Share and Size Forecast to 2029
  • Blockchain in healthcare Market – Industry Trends and Forecast to 2029
  • Artificial Intelligence in Healthcare Market 2022 Size, Status and Clinical Insights | Koninklijke Philips, Intel, IBM, Medtronic
  • Preventive Healthcare Market by Type, Model Type, Organization Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2029
  • CBD Oil Market is Booming with a Large Industrial Scope | Report Analysis on Expansion, Share, Revenue, Latest and Future Trends (2022-2029)

i-Factor: Live Market intelligence platform 

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister 

Brandessence Market Research & Consulting Pvt ltd. 

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London. 

Follow Us: Linkedin  

Blog:What is Market Research?
What is Market Sizing? How to Measure Your TAM, SAM, and SOM

Contact: 
Mr. Vishal Sawant  
Email: vishal@brandessenceresearch.com  
Email: Sales@brandessenceresearch.com  
Corporate Sales: +44-2038074155  
Asia Office: +917447409162 

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.